Use of varenicline in the treatment of smokers with cardiovascular disease

S. Solano Reina, L. Perera Lopez, P. Vaquero Lozano, R. Solano Garcia-Tenorio, T. Lopez Ruiz, C. A. Jiminez Ruiz, J. I. de Granda Orive (Madrid, Spain)

Source: Annual Congress 2013 –Smoking cessation
Session: Smoking cessation
Session type: Poster Discussion
Number: 4940

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Solano Reina, L. Perera Lopez, P. Vaquero Lozano, R. Solano Garcia-Tenorio, T. Lopez Ruiz, C. A. Jiminez Ruiz, J. I. de Granda Orive (Madrid, Spain). Use of varenicline in the treatment of smokers with cardiovascular disease. Eur Respir J 2013; 42: Suppl. 57, 4940

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effectiveness of treatment with varenicline in smokers with cardiovascular diseases (CVD)
Source: Annual Congress 2009 - Smoking cessation
Year: 2009


Smoking cessation treatment for COPD smokers
Source: Annual Congress 2011 - Smoking cessation science
Year: 2011


Smoking cessation and COPD
Source: Eur Respir Rev 2013; 22: 37-43
Year: 2013



Smoking cessation in asthma patients
Source: International Congress 2017 – PG14 Smoking cessation in patients with respiratory diseases
Year: 2017

Pharmacological treatment for smoking cessation on COPD smokers
Source: Annual Congress 2011 - PG19 How to set up and deliver a smoking cessation service in a pulmonology department
Year: 2011



Comparison of effectiveness of varenicline and NRTs in smoking cessation in patients with chronic diseases
Source: Annual Congress 2008 - Smoking cessation and new tobacco uses
Year: 2008


Smoking cessation treatment in smokers with psychiatric problems
Source: Annual Congress 2008 - Towards smoking cessation
Year: 2008


Effectiveness of smoking cessation in patients with psychiatric disease
Source: Annual Congress 2012 - Tobacco comorbidity
Year: 2012


Smoking cessation for COPD
Source: Annual Congress 2009 - PG6 Core Curriculum Postgraduate Course: How to reduce the burden of COPD
Year: 2009



Smoking habit, smoking cessation and relapse rates in patients with comorbid diseases
Source: Annual Congress 2010 - Smoking cessation interventions
Year: 2010

Smoking cessation compared to treatment of COPD and other smoking-related diseases using cost-effectiveness evidence
Source: Annual Congress 2009 - Sustainability in treatment of COPD patients according to economics and quality of care
Year: 2009



Smoking cessation in asthmatic patients
Source: Annual Congress 2013 –Smoking cessation
Year: 2013


Smoking cessation
Source: Respipedia Article
Year: 2018

Quitting smoking and reduction of cardiovascular risk factors
Source: International Congress 2016 – Smoking-related diseases
Year: 2016


Causes of quitting treatment with varenicline in a smoking cessation clinic
Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation
Year: 2009

Smoking cessation by hospitalization yields a high rate of smoke abstinence in COPD-patients
Source: Annual Congress 2007 - Smoking and COPD
Year: 2007




Evaluation of the effect of quit smoking with arteriosclerosis index in COPD patients
Source: International Congress 2014 – Three smoking-related diseases: cardiovascular, lung cancer and infection
Year: 2014